Clinical Trial Update: Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Amaryl M 1/500 mg twice daily versus Amaryl 4 mg, both in combination with Lantus, for efficacy and safety in Type 2 Diabetes M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Amaryl (glimepiride)
• Lantus (insulin glargine)

Snippet

Sponsor: Handok Inc. | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED